Venture Capital

Sciety

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Seed, Early Stage, Series A, Series B

Geographical Focus
Denmark, Sweden, Norway, Finland, Iceland

Industries Focus

  • Pharmaceuticals
  • Biotechnology
  • Health Tech
  • Medical Technology

Investment Size:
5,000,000 to 30,000,000 USD

Investor Details Founded: 2014

Sciety is a prominent venture capital firm dedicated to supporting the growth of innovative life science and health tech companies across the Nordic region. With a focus on biotechnology, pharmaceuticals, medical technology, and health tech, Sciety invests alongside its network of family offices, private investors, and other venture capital firms to bring healthcare breakthroughs to a global audience.

The firm's investment strategy encompasses seed, early-stage, Series A, and Series B funding, with typical deal sizes ranging from €5 million to €30 million. Sciety's geographical focus includes Sweden, Norway, Denmark, Finland, and Iceland, reflecting its commitment to fostering innovation within the Nordic life science sector.

Over the years, Sciety has built a strong track record, investing over one billion SEK in 26 companies, with eight achieving successful exits through acquisitions or public listings. This success underscores Sciety's effective approach to identifying and nurturing high-potential companies in the life science and health tech industries.

Requirements
  • Innovative life science and health tech companies in the Nordic region seeking seed to Series B funding
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • PeptiSystems
  • Akiram Therapeutics
  • Encare
  • Single Technologies
Claim this Investor

Are you an official representative of Sciety?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim